Phenacemide
From Infogalactic: the planetary knowledge core
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
N-carbamoyl-2-phenyl-acetamide
|
|
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pharmacokinetic data | |
| Biological half-life | 22-25 hours. |
| Identifiers | |
| CAS Number | 63-98-9  |
| ATC code | N03AX07 (WHO) |
| PubChem | CID: 4753 |
| IUPHAR/BPS | 7265 |
| DrugBank | DB01121 |
| ChemSpider | 4589 |
| UNII | PAI7J52V09 |
| KEGG | D00504 |
| ChEMBL | CHEMBL918 |
| Chemical data | |
| Formula | C9H10N2O2 |
| Molecular mass | 178.188 g/mol |
|
|
|
|
| (verify) | |
Phenacemide (INN, BAN) (brand name Phenurone), also known as phenylacetylurea, is an anticonvulsant of the ureide (acetylurea) class.[1] It is a congener and ring-opened analogue of phenytoin (a hydantoin),[2][3] and is structurally related to the barbiturates and to other hydantoins.[4] Phenacemide was introduced in 1949 for the treatment of epilepsy, but was eventually withdrawn due to toxicity.[2][3]
See also
References
External links
- MedlinePlus DrugInfo uspdi-202454
- Lua error in package.lua at line 80: module 'strict' not found.
- Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
